156 related articles for article (PubMed ID: 33444684)
1. Super-enhancers for RUNX3 are required for cell proliferation in EBV-infected B cell lines.
Hosoi H; Niibori-Nambu A; Nah GSS; Bahirvani AG; Mok MMH; Sanda T; Kumar AP; Tenen DG; Ito Y; Sonoki T; Osato M
Gene; 2021 Mar; 774():145421. PubMed ID: 33444684
[TBL] [Abstract][Full Text] [Related]
2. RUNX super-enhancer control through the Notch pathway by Epstein-Barr virus transcription factors regulates B cell growth.
Gunnell A; Webb HM; Wood CD; McClellan MJ; Wichaidit B; Kempkes B; Jenner RG; Osborne C; Farrell PJ; West MJ
Nucleic Acids Res; 2016 Jun; 44(10):4636-50. PubMed ID: 26883634
[TBL] [Abstract][Full Text] [Related]
3. TAF Family Proteins and MEF2C Are Essential for Epstein-Barr Virus Super-Enhancer Activity.
Wang C; Jiang S; Zhang L; Li D; Liang J; Narita Y; Hou I; Zhong Q; Gewurz BE; Teng M; Zhao B
J Virol; 2019 Aug; 93(16):. PubMed ID: 31167905
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus nuclear antigen 3A partially coincides with EBNA3C genome-wide and is tethered to DNA through BATF complexes.
Schmidt SC; Jiang S; Zhou H; Willox B; Holthaus AM; Kharchenko PV; Johannsen EC; Kieff E; Zhao B
Proc Natl Acad Sci U S A; 2015 Jan; 112(2):554-9. PubMed ID: 25540416
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr Virus Episome Physically Interacts with Active Regions of the Host Genome in Lymphoblastoid Cells.
Wang L; Laing J; Yan B; Zhou H; Ke L; Wang C; Narita Y; Zhang Z; Olson MR; Afzali B; Zhao B; Kazemian M
J Virol; 2020 Nov; 94(24):. PubMed ID: 32999023
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of RUNX1 by RUNX3 requires the RUNX3 VWRPY sequence and is essential for Epstein-Barr virus-driven B-cell proliferation.
Brady G; Whiteman HJ; Spender LC; Farrell PJ
J Virol; 2009 Jul; 83(13):6909-16. PubMed ID: 19403666
[TBL] [Abstract][Full Text] [Related]
7. Phase Separation of Epstein-Barr Virus EBNA2 and Its Coactivator EBNALP Controls Gene Expression.
Peng Q; Wang L; Qin Z; Wang J; Zheng X; Wei L; Zhang X; Zhang X; Liu C; Li Z; Wu Y; Li G; Yan Q; Ma J
J Virol; 2020 Mar; 94(7):. PubMed ID: 31941785
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus oncoprotein super-enhancers control B cell growth.
Zhou H; Schmidt SC; Jiang S; Willox B; Bernhardt K; Liang J; Johannsen EC; Kharchenko P; Gewurz BE; Kieff E; Zhao B
Cell Host Microbe; 2015 Feb; 17(2):205-16. PubMed ID: 25639793
[TBL] [Abstract][Full Text] [Related]
9. Roles of RUNX in B Cell Immortalisation.
West MJ; Farrell PJ
Adv Exp Med Biol; 2017; 962():283-298. PubMed ID: 28299664
[TBL] [Abstract][Full Text] [Related]
10. RUNX3 is oncogenic in natural killer/T-cell lymphoma and is transcriptionally regulated by MYC.
Selvarajan V; Osato M; Nah GSS; Yan J; Chung TH; Voon DC; Ito Y; Ham MF; Salto-Tellez M; Shimizu N; Choo SN; Fan S; Chng WJ; Ng SB
Leukemia; 2017 Oct; 31(10):2219-2227. PubMed ID: 28119527
[TBL] [Abstract][Full Text] [Related]
11. CRISPR/Cas9 Screens Reveal Epstein-Barr Virus-Transformed B Cell Host Dependency Factors.
Ma Y; Walsh MJ; Bernhardt K; Ashbaugh CW; Trudeau SJ; Ashbaugh IY; Jiang S; Jiang C; Zhao B; Root DE; Doench JG; Gewurz BE
Cell Host Microbe; 2017 May; 21(5):580-591.e7. PubMed ID: 28494239
[TBL] [Abstract][Full Text] [Related]
12. Identification of Epstein-Barr virus (EBV) nuclear antigen 2 (EBNA2) target proteins by proteome analysis: activation of EBNA2 in conditionally immortalized B cells reflects early events after infection of primary B cells by EBV.
Schlee M; Krug T; Gires O; Zeidler R; Hammerschmidt W; Mailhammer R; Laux G; Sauer G; Lovric J; Bornkamm GW
J Virol; 2004 Apr; 78(8):3941-52. PubMed ID: 15047810
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus super-enhancer eRNAs are essential for MYC oncogene expression and lymphoblast proliferation.
Liang J; Zhou H; Gerdt C; Tan M; Colson T; Kaye KM; Kieff E; Zhao B
Proc Natl Acad Sci U S A; 2016 Dec; 113(49):14121-14126. PubMed ID: 27864512
[TBL] [Abstract][Full Text] [Related]
14. c-myc activation renders proliferation of Epstein-Barr virus (EBV)-transformed cells independent of EBV nuclear antigen 2 and latent membrane protein 1.
Polack A; Hörtnagel K; Pajic A; Christoph B; Baier B; Falk M; Mautner J; Geltinger C; Bornkamm GW; Kempkes B
Proc Natl Acad Sci U S A; 1996 Sep; 93(19):10411-6. PubMed ID: 8816814
[TBL] [Abstract][Full Text] [Related]
15. The Epstein-Barr Virus Regulome in Lymphoblastoid Cells.
Jiang S; Zhou H; Liang J; Gerdt C; Wang C; Ke L; Schmidt SCS; Narita Y; Ma Y; Wang S; Colson T; Gewurz B; Li G; Kieff E; Zhao B
Cell Host Microbe; 2017 Oct; 22(4):561-573.e4. PubMed ID: 29024646
[TBL] [Abstract][Full Text] [Related]
16. Role of EBV and Ig/myc translocation in Burkitt lymphoma.
Klein G
Antibiot Chemother (1971); 1994; 46():110-6. PubMed ID: 7826031
[No Abstract] [Full Text] [Related]
17. MYC Controls the Epstein-Barr Virus Lytic Switch.
Guo R; Jiang C; Zhang Y; Govande A; Trudeau SJ; Chen F; Fry CJ; Puri R; Wolinsky E; Schineller M; Frost TC; Gebre M; Zhao B; Giulino-Roth L; Doench JG; Teng M; Gewurz BE
Mol Cell; 2020 May; 78(4):653-669.e8. PubMed ID: 32315601
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr Virus Nuclear Antigen Leader Protein Coactivates EP300.
Wang C; Zhou H; Xue Y; Liang J; Narita Y; Gerdt C; Zheng AY; Jiang R; Trudeau S; Peng CW; Gewurz BE; Zhao B
J Virol; 2018 May; 92(9):. PubMed ID: 29467311
[TBL] [Abstract][Full Text] [Related]
19. Identification of MEF2B, EBF1, and IL6R as Direct Gene Targets of Epstein-Barr Virus (EBV) Nuclear Antigen 1 Critical for EBV-Infected B-Lymphocyte Survival.
Tempera I; De Leo A; Kossenkov AV; Cesaroni M; Song H; Dawany N; Showe L; Lu F; Wikramasinghe P; Lieberman PM
J Virol; 2016 Jan; 90(1):345-55. PubMed ID: 26468528
[TBL] [Abstract][Full Text] [Related]
20. Modulation of cellular gene expression in B lymphoma cells following in vitro infection by Epstein-Barr virus (EBV).
Calender A; Cordier M; Billaud M; Lenoir GM
Int J Cancer; 1990 Oct; 46(4):658-63. PubMed ID: 1698730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
